Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients

HAART largely decreases morbidity and mortality in chronic HIV-1-infected patients, but immune nonresponders (INRs) with full viral suppression still fail to reverse the immune deficiency. This study evaluated the safety and immunological responses of human umbilical cord mesenchymal stem cell (MSC)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2013-05, Vol.27 (8), p.1283-1293
Hauptverfasser:	ZHENG ZHANG, JUNLIANG FU, LISHAN SU, WANG, Fu-Sheng, XIANGSHENG XU, SIYU WANG, RUONAN XU, MIN ZHAO, WEIMIN NIE, XICHENG WANG, JIYUAN ZHANG, TAISHENG LI
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent AIDS/HIV Biological and medical sciences CD4 Lymphocyte Count CD4-Positive T-Lymphocytes - immunology Child Child, Preschool Female HIV Infections - immunology HIV Infections - therapy HIV-1 - immunology Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infant Infectious diseases Male Medical sciences Mesenchymal Stem Cell Transplantation Mesenchymal Stromal Cells - immunology Pilot Projects Prospective Studies Treatment Outcome Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!